XML 21 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
Research and development $ 41,364 $ 36,966
General and administrative 16,651 7,682
Total operating expenses 58,015 44,648
Loss from operations (58,015) (44,648)
Other income, net:    
Change in fair value of SAFE liabilities (3,610) 1,255
Loss on issuance of SAFEs 0 (255)
Interest income 4,261 581
Interest expense (107) (152)
Other expense (511) 396
Total other income, net 33 1,825
Net loss (57,982) (42,823)
Other comprehensive loss:    
Foreign currency translation adjustment 9 (11)
Comprehensive loss $ (57,973) $ (42,834)
Net loss per share, basic $ (6.83) $ (33.76)
Net loss per share, diluted $ (6.83) $ (33.76)
Weighted-average common shares outstanding, basic 8,490,171 1,268,512
Weighted-average common shares outstanding, diluted 8,490,171 1,268,512